PGY1 resident @jasmforrest led today's @UK_COP "Conversations about Teaching" session on this @TheAJPE article. Still, lots of questions remain....such as:
"Where do you draw the line on information that must be memorized and information that can be looked up?"
#pharmed
In our @JAMA_current editorial, we tackle a timely question in #CardioTwitter: should we recommend #apixaban or #rivaroxaban as first-line anticoagulant for #Afib?The two #DOACs are not interchangeable for bleeding or stroke. Let's review all RCTs & RWE🧵
https://t.co/G1AE19AZqC